Open Access

Panel Discussion: The case for combination therapy: The way forward in intensive LDL-c management?

Congress Session

About the speaker

Professor John Kastelein

Faculty of Medecine - University of Amsterdam, Amsterdam (Netherlands (The))
21 presentations
1 follower

3 more presentations in this session

LDL-c in the management of high CV risk: Changing the paradigm for prevention.

Speaker: Professor K. Ray (London, GB)

Thumbnail

The urgency to treat LDL-c post MI: The role of PCSK9 mAbs in reaching goals.

Speaker: Professor D. Connolly (Birmingham, GB)

Thumbnail

Expanding therapeutic options for lowering LDL-c: Where will bempedoic acid and inclisiran contribute.

Speaker: Doctor C. Ballantyne (Houston, US)

Thumbnail

Access the full session

Redefining intensive LDL-c management in high risk patients: The case for combination therapy

Speakers: Professor J. Kastelein, Professor K. Ray, Professor D. Connolly, Doctor C. Ballantyne
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

EHRA Premium Access

Effectiveness and safety of edoxaban in 27,333 patients from ETNA-AF with and without a history of intracranial haemorrhage after 2 years of treatment

4 April 2022

ACVC Premium Access

Cardiogenic shock: state of the art 2022 - discussion.

19 March 2022

ACVC Premium Access

Pharmacological treatment: how to choose your drug (if any)

19 March 2022

This platform is supported by

logo Novo Nordisk